We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-12.35%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$14.3B
AUM Growth
-$444M
Cap. Flow
+$1.68B
Cap. Flow %
11.73%
Top 10 Hldgs %
21.62%
Holding
1,821
New
56
Increased
555
Reduced
957
Closed
250

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$101M
2
AMZN icon
Amazon
AMZN
+$99.5M
3
MSFT icon
Microsoft
MSFT
+$95.8M
4
LIN icon
Linde
LIN
+$84.2M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$40.4M

Sector Composition

Rank Sector Weight
1 Technology 19.27%
2 Healthcare 13.08%
3 Financials 12.21%
4 Consumer Discretionary 10.94%
5 Consumer Staples 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTD icon
1026
Trade Desk
TTD
$8.13B
$407K ﹤0.01%
35,110
-4,700
-12% -$58.8K
AMPH icon
1027
Amphastar Pharmaceuticals
AMPH
$825M
$405K ﹤0.01%
20,343
-3,746
-16% -$73.8K
VRNT
1028
DELISTED
Verint Systems
VRNT
$403K ﹤0.01%
18,690
-4,413
-19% -$101K
WWW icon
1029
Wolverine World Wide
WWW
$1.54B
$402K ﹤0.01%
12,620
-1,349
-10% -$45.9K
MMSI icon
1030
Merit Medical Systems
MMSI
$4.43B
$399K ﹤0.01%
7,151
-753
-10% -$44.8K
CFFN icon
1031
Capitol Federal Financial
CFFN
$1.08B
$398K ﹤0.01%
31,137
-2,588
-8% -$33.2K
BTU icon
1032
Peabody Energy
BTU
$2.78B
$396K ﹤0.01%
12,989
-2,426
-16% -$81.3K
TTEK icon
1033
Tetra Tech
TTEK
$8.23B
$395K ﹤0.01%
38,175
-4,220
-10% -$52.3K
BCRX icon
1034
BioCryst Pharmaceuticals
BCRX
$2.37B
$393K ﹤0.01%
48,660
-9,293
-16% -$72.3K
BOLD
1035
DELISTED
Audentes Therapeutics, Inc
BOLD
$392K ﹤0.01%
18,376
-824
-4% -$21.3K
CRS icon
1036
Carpenter Technology
CRS
$30B
$390K ﹤0.01%
10,943
-2,004
-15% -$90.4K
NAVI icon
1037
Navient
NAVI
$774M
$389K ﹤0.01%
44,207
-6,331
-13% -$72.6K
NXST icon
1038
Nexstar Media Group
NXST
$5.6B
$387K ﹤0.01%
4,918
-839
-15% -$66.4K
HUBB icon
1039
Hubbell
HUBB
$25.7B
$386K ﹤0.01%
3,888
-951
-20% -$104K
PDCE
1040
DELISTED
PDC Energy, Inc.
PDCE
$386K ﹤0.01%
12,977
-95
-0.7% -$3.81K
BKU icon
1041
Bankunited
BKU
$3.38B
$385K ﹤0.01%
12,847
-885
-6% -$28.8K
TXMD icon
1042
TherapeuticsMD
TXMD
$23.8M
$381K ﹤0.01%
1,998
-369
-16% -$90K
UA icon
1043
Under Armour Class C
UA
$2.92B
$380K ﹤0.01%
23,506
+2,998
+15% +$56.7K
KBR icon
1044
KBR
KBR
$4.68B
$379K ﹤0.01%
24,938
-4,807
-16% -$89.9K
MTDR icon
1045
Matador Resources
MTDR
$6.31B
$379K ﹤0.01%
24,383
-2,175
-8% -$54.7K
DNB
1046
DELISTED
Dun & Bradstreet
DNB
$376K ﹤0.01%
2,637
-667
-20% -$95.1K
DNKN
1047
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$375K ﹤0.01%
5,841
-1,587
-21% -$113K
NTCT icon
1048
NETSCOUT
NTCT
$2.86B
$374K ﹤0.01%
15,808
-4,464
-22% -$112K
PGEN icon
1049
Precigen
PGEN
$1.93B
$369K ﹤0.01%
56,356
+44,834
+389% +$502K
LHCG
1050
DELISTED
LHC Group LLC
LHCG
$369K ﹤0.01%
3,927
-416
-10% -$39.8K

Similar funds

ProShare Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, ProShare Advisors held 1,821 positions worth $14.3B, down 3% from $14.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

ProShare Advisors deployed $1.68B of net new capital in Q4 2018, opening 56 new positions and adding to 555 existing holdings. Its largest new stake was Linde: 532,831 shares worth $83.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was McCormick & Company Non-Voting, an estimated $14.7M trimmed.

  • ProShare Advisors's largest Q4 2018 buy was Linde: 532,831 shares worth $83.1M.
  • ProShare Advisors added most to Apple in Q4 2018, an estimated $101M increase.
  • ProShare Advisors's biggest Q4 2018 reduction was McCormick & Company Non-Voting, cutting an estimated $14.7M.
  • ProShare Advisors fully exited Praxair Inc in Q4 2018, selling an estimated $77.4M.
  • ProShare Advisors's ten largest holdings make up 22% of its $14.3B portfolio in Q4 2018.
  • ProShare Advisors opened 56 new positions and closed 250 in Q4 2018.
  • ProShare Advisors's portfolio value fell 3% quarter-over-quarter to $14.3B.

Based on ProShare Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.